ES2077582T3 - Derivados de proteinas y un procedimiento para su preparacion. - Google Patents

Derivados de proteinas y un procedimiento para su preparacion.

Info

Publication number
ES2077582T3
ES2077582T3 ES89308681T ES89308681T ES2077582T3 ES 2077582 T3 ES2077582 T3 ES 2077582T3 ES 89308681 T ES89308681 T ES 89308681T ES 89308681 T ES89308681 T ES 89308681T ES 2077582 T3 ES2077582 T3 ES 2077582T3
Authority
ES
Spain
Prior art keywords
protein
group
peptide
procedure
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89308681T
Other languages
English (en)
Inventor
Robin Ewart Offord
Keith Rose
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of ES2077582T3 publication Critical patent/ES2077582T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57575—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving oncogenic proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

DERIVADOS DE LA PROTEINA DE FORMULA (I), DONDE A-CO ES UN RESIDUO DE UNA PROTEINA O PEPTIDO A-CO2H (ESPECIALMENTE DONDE -CO2H ES EL GRUPO CARBOXILICO TERMINAL -C DE LA PROTEINA O PEPTIDO); R1, R2, R3 Y R4 PUEDEN SER IGUALES O DIFERENTES Y PUEDEN ESTAR PRESENTES O AUSENTES EN CADA UNO DE ELLOS, V UN GRUPO ESPACIADOR, X ES UN OXIGENO O UN ATOMO DE SULFURO; Y LAS SALES DEL MISMO. LOS COMPUESTOS PUEDEN SER PREPARADOS POR UNA REACCION CONDENSACION, ESPECIALMENTE EN LA PRESENCIA DE UNA ENZIMA CAPAZ DE CATALIZAR LA FORMACION DE UN ENLACE PEPTIDO. LOS COMPUESTOS PUEDEN SER USADOS PARA FORMAR PROTEINAS CONJUGADAS EN LAS CUALES UN GRUPO DE INTERES COMO SON OTRA PROTEINA O PEPTIDO O UN GRUPO REPORTADOR REALIZADOR ES ACOPLADO A LA PROTEINA A TRAVES DE UN GRUPO -N (R'') N (R2) - Z'' - C (=X) - Z2 - N (R3) N.
ES89308681T 1988-08-26 1989-08-25 Derivados de proteinas y un procedimiento para su preparacion. Expired - Lifetime ES2077582T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888820378A GB8820378D0 (en) 1988-08-26 1988-08-26 Chemical compounds

Publications (1)

Publication Number Publication Date
ES2077582T3 true ES2077582T3 (es) 1995-12-01

Family

ID=10642823

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89308681T Expired - Lifetime ES2077582T3 (es) 1988-08-26 1989-08-25 Derivados de proteinas y un procedimiento para su preparacion.

Country Status (9)

Country Link
EP (1) EP0359428B1 (es)
JP (1) JP2778775B2 (es)
AT (1) ATE126236T1 (es)
AU (1) AU637326B2 (es)
DE (1) DE68923746T2 (es)
ES (1) ES2077582T3 (es)
GB (1) GB8820378D0 (es)
GR (1) GR3017089T3 (es)
WO (1) WO1990002136A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8610551D0 (en) 1986-04-30 1986-06-04 Hoffmann La Roche Polypeptide & protein derivatives
US6673347B1 (en) 1986-04-30 2004-01-06 Gryphon Therapeutics Polypeptide and protein derivatives and process for their preparation
GB9004538D0 (en) * 1990-02-28 1990-04-25 Offord Robin E Chemical compounds
WO1992001476A1 (en) * 1990-07-26 1992-02-06 University Of Iowa Research Foundation Novel drug delivery systems for proteins and peptides using albumin as a carrier molecule
US5272253A (en) * 1991-07-01 1993-12-21 Eli Lilly And Company Cluster conjugates of drugs with antibodies
GB9525955D0 (en) * 1995-12-19 1996-02-21 Therexsys Ltd Improved pharmaceutical compositions
US5830852A (en) * 1995-12-19 1998-11-03 Cobra Therapeutics, Ltd. Compositions for insulin-receptor mediated nucleic acid delivery
US7118737B2 (en) 2000-09-08 2006-10-10 Amylin Pharmaceuticals, Inc. Polymer-modified synthetic proteins
DE602006019824D1 (de) 2005-01-26 2011-03-10 Univ Ramot Biologisch aktive silberbeschichtete proteine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL71947A (en) * 1984-05-29 1987-10-30 Yeda Research And Dev Comp Ltd Enzyme hydrazides and method for detection and determination of glycoconjugates
PH26813A (en) * 1987-09-02 1992-11-05 Ciba Geigy Ag Conjugates of cytokines with immunoglobulins

Also Published As

Publication number Publication date
JPH03501623A (ja) 1991-04-11
DE68923746D1 (de) 1995-09-14
GB8820378D0 (en) 1988-09-28
GR3017089T3 (en) 1995-11-30
JP2778775B2 (ja) 1998-07-23
AU4190689A (en) 1990-03-23
AU637326B2 (en) 1993-05-27
EP0359428B1 (en) 1995-08-09
DE68923746T2 (de) 1996-03-21
EP0359428A1 (en) 1990-03-21
WO1990002136A1 (en) 1990-03-08
ATE126236T1 (de) 1995-08-15

Similar Documents

Publication Publication Date Title
AR246275A1 (es) Composiciones de catalizador, procedimiento para la preparacion de polimeros de monoxido de carbono, y eteno y nuevo compuesto.
ATE254138T1 (de) An den erythropoietin-rezeptor bindende zusammensetzungen und peptide
ES2077643T3 (es) Compuestos antivirales.
ES2032749T3 (es) Acidos oxoftalazinil-aceticos heterociclicos.
NO904430L (no) Fremgangsmaate for fremstilling av fibrinogenreseptor-antagonister.
GR3006172T3 (es)
ES2086341T3 (es) Derivados de aminoacidos con propiedades inhibidoras de la renina, procedimiento para su preparacion, agentes que los contienen y su utilizacion.
ES8800679A1 (es) Un procedimiento para preparar derivados de piperiliden-dihidrodibenzo-(a,d)-cicloheptenos y derivados aza
ES8505518A1 (es) Procedimiento para preparar derivados de aminoacidos
ATE51617T1 (de) Verfahren zur herstellung von 4-phenyl-pyrrolderivaten.
YU46814B (sh) Fuzioni polipeptid koji sadrži dvojne jedinice ponavljanja cirkumsporozoitnog (cs) proteina plasmodium falciparum
ATE126236T1 (de) Protein-derivate und verfahren zu ihrer herstellung.
ES2083387T3 (es) Peptidos sinteticos y sus mezclas para la deteccion de anticuerpos hiv.
ES2128554T3 (es) Nuevos derivados del acido glutamico, procedimiento para su preparacion y su utilizacion como medicamentos para el aumento de la memoria y aprendizaje.
MX173414B (es) Sistema acuoso que contiene derivados de acido amino sulfonico de los acidos carboxilicos
ES2058383T3 (es) Derivados de acidos carboxilicos azaciclicos, su preparacion y uso.
ES8702433A1 (es) Un procedimiento para la preparacion de un compuesto heterociclico sustituido con peptidos.
DK443988A (da) Injektionspraeparat indeholdende modificeret tpa
ATE64740T1 (de) Platin enthaltender cytostatischer wirkstoff.
ES2085950T3 (es) Derivados del acido 1,4-benzotiazina-2-acetico, procedimientos para su produccion y su uso.
UA26443A (uk) Похідhі 20,21-диhоребурhамеhіhу, їх рацемати або оптичhі ізомери, або їх адитивhі солі з оргаhічhими кислотами, що мають hоотропhі та аhтидепресивhі властивості
ES2058576T3 (es) Compuestos activos sobre las formas tisulares de la malaria y procedimiento de preparacion.
IT1222414B (it) Composizioni farmaceutiche contenenti trapidil,loro procedimento di preparazione e relaticvo impiego terapeutico
ES2052752T3 (es) Derivados de aminoquinoleina antimalarica, procedimiento de preparacion y composicion farmaceutica que contiene los mismos.
DE69925911D1 (de) Immunodiagnostischer wirkstoff zum nachweiss von maedi-visna virus und caev infektionen

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 359428

Country of ref document: ES